Assets sold to Merck.
 
 
A discovery based chemistry company providing high throughput design, screening, synthesis and purification technologies aimed at improving and accelerating processes for the discovery of novel chemical entities.
(now NASDAQ: INFI)
 
 
Biopharmaceutical company that is utilizing their expertise in marine
biology to discover and develop clinically relevant compounds for the
treatment of inflammation, cancer, and infectious diseases.